These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 7153622
1. [Experimental studies on specific active immunotherapy using immune response of irradiated tumor tissues. 5. A combined effect of the immune response of cryopreserved tissue and OK-432]. Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Aug 20; 17(5):1305-10. PubMed ID: 7153622 [No Abstract] [Full Text] [Related]
2. [Experimental studies on specific active immunotherapy using immune responses of irradiated tumor tissue. 4. Effects of a combined use of a non-specific immunopotentiator, OK-432]. Imanaka K, Ogawa Y, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Aug 20; 17(5):1299-304. PubMed ID: 7153621 [No Abstract] [Full Text] [Related]
3. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 3. Effect of the cryopreserved immune reaction]. Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Aug 20; 17(5):1293-8. PubMed ID: 7153620 [No Abstract] [Full Text] [Related]
4. [Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432]. Mukae S, Norimura T, Tsuchiya T. Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun 25; 47(6):838-44. PubMed ID: 3684525 [No Abstract] [Full Text] [Related]
6. [Experimental study on active specific immunotherapy utilizing the immune reaction of irradiated tumor tissue. 7. Effect of the cryopreserved immunoreactive cells combined with PSK]. Ogawa Y, Maeda T, Yoshida S, Yamamoto Y, Morita M, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1983 Apr 20; 18(3):682-5. PubMed ID: 6619634 [No Abstract] [Full Text] [Related]
7. [Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432]. Kan N, Inamoto T, Hori T, Nio Y, Tsuchitani T, Kodama H, Tobe T, Ohgaki K. Nihon Gan Chiryo Gakkai Shi; 1985 May 20; 20(4):784-96. PubMed ID: 3877129 [No Abstract] [Full Text] [Related]
10. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings]. Kokunai I, Mori T, Yayoi E, Matuura N, Kosaki G. Nihon Geka Gakkai Zasshi; 1985 Mar 20; 86(3):258-65. PubMed ID: 3982380 [Abstract] [Full Text] [Related]
11. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells]. Yamagishi H, Naito K, Maeda Y, Kobayashi M, Kurioka H, Fujimori C, Tanaka T, Hashimoto I. Gan To Kagaku Ryoho; 1983 Jul 20; 10(7):1670-8. PubMed ID: 6870309 [Abstract] [Full Text] [Related]
12. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide]. Norimura T, Kunugita N, Dohi S, Mukae S, Tsuchiya T. Gan No Rinsho; 1988 Oct 20; 34(13):1811-5. PubMed ID: 3199515 [Abstract] [Full Text] [Related]
13. [Immune responses and clinical effects of OK-432 immunotherapy in lung neoplasms]. Watanabe H, Komori Y, Yamada T, Iwa T. Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr 20; 27(4):451-8. PubMed ID: 469305 [No Abstract] [Full Text] [Related]
14. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy]. Kawata H. Nihon Geka Gakkai Zasshi; 1984 Nov 20; 85(11):1479-89. PubMed ID: 6521727 [Abstract] [Full Text] [Related]
15. [A study of the synergy of microwave coagulation and streptococcal preparation (OK-432) in experimental tumors in relation to interleukin 2 producing activity]. Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Egawa H, Noguchi H, Nagai Y, Kobayashi Y, Mori K. Nihon Geka Hokan; 1986 Sep 01; 55(5):689-99. PubMed ID: 3495246 [No Abstract] [Full Text] [Related]
16. [The effect of OK-432 on modifying a spontaneous lung metastasis from murine fibrosarcomas]. Ito H, Yamada S, Nishiguchi I, Shigematsu N, Nakayama T, Kuribayashi T, Hashimoto S. Gan No Rinsho; 1990 Aug 01; 36(9):993-7. PubMed ID: 2381054 [Abstract] [Full Text] [Related]
17. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination]. Mukai M, Ando K, Koike S, Ishikawa T, Ryu M, Nagashima T, Nagao K, Isono K. Gan To Kagaku Ryoho; 1986 Mar 01; 13(3 Pt 1):556-62. PubMed ID: 3954378 [Abstract] [Full Text] [Related]
18. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]. Kan N, Okino T, Nakanishi M, Sato K, Mise K, Teramura Y, Yamasaki S, Hori T, Ohgaki K, Tobe T. Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379 [Abstract] [Full Text] [Related]
19. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice. Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S. J Biol Response Mod; 1988 Aug 01; 7(4):371-83. PubMed ID: 3139841 [Abstract] [Full Text] [Related]
20. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain. Saito H, Tomioka H, Sato K. Hiroshima J Med Sci; 1983 Jun 01; 32(2):231-4. PubMed ID: 6352569 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]